Human endogenous retrovirus-H long terminal repeat-associating 2: The next immune checkpoint for antitumour therapy

被引：15
|
作者：
Ying, Honggang [1 ,2 ,3 ,4 ,5 ]
Xu, Jian [1 ,2 ,3 ,4 ,5 ]
Zhang, Xiaozhen [1 ,2 ,3 ,4 ,5 ]
Liang, Tingbo [1 ,2 ,3 ,4 ,5 ]
Bai, Xueli [1 ,2 ,3 ,4 ,5 ]
机构：
[1] Zhejiang Univ, Affiliated Hosp 1, Sch Med, Dept Hepatobiliary & Pancreat Surg, Hangzhou 310003, Zhejiang, Peoples R China
[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Zhejiang Prov Key Lab Pancreat Dis, 79 Qingchun Rd, Hangzhou 310003, Zhejiang, Peoples R China
[3] Zhejiang Prov Innovat Ctr Study Pancreat Dis, Hangzhou 310003, Zhejiang, Peoples R China
[4] Zhejiang Prov Clin Res Ctr Study Hepatobiliary &, Hangzhou 310003, Zhejiang, Peoples R China
[5] Zhejiang Univ, Canc Ctr, Hangzhou 310058, Zhejiang, Peoples R China
来源：
EBIOMEDICINE | 2022年 / 79卷
基金：
中国国家自然科学基金;
关键词：
HHLA2; TMIGD2; KIR3DL3; Immune checkpoint; Cancer immunotherapy; B7; FAMILY-MEMBER; CANCER-IMMUNOTHERAPY; PROGNOSTIC-SIGNIFICANCE; CELL-ADHESION; HHLA2; IDENTIFICATION; EXPRESSION; SURVIVAL; IGPR-1; OVEREXPRESSION;
D O I：
10.1016/j.ebiom.2022.103987
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Human endogenous retrovirus-H long terminal repeat-associating 2 (HHLA2) is a newly emerging immune checkpoint that belongs to B7 family. HHLA2 has a co-stimulatory receptor transmembrane and immunoglobulin domain containing 2 (TMIGD2) and a newly discovered co-inhibitory receptor killer cell Ig-like receptor, three Ig domains, and long cytoplasmic tail (KIR3DL3), which endows it with both immunostimulant and immunosuppression functions in cancer development. In this review, we summarize the HHLA2 expression profile in human cancers, its association with cancer prognosis and clinical features, and its dual roles in regulating cancer immune response through up-to-date literatures. Furthermore, we highlight that precision cancer immunotherapy through manipulating HHLA2-KIR3DL3/TMIGD2 interaction is a promising antitumour strategy.
引用
收藏
页数：11
相关论文
共 34 条
  • [1] Human endogenous retrovirus-H long terminal repeat-associating 2: an emerging immune checkpoint for cancer immunotherapy
    Cao, Zeya
    Wang, Youping
    Cheng, Shih-Chin
    He, Nanhai
    JOURNAL OF LEUKOCYTE BIOLOGY, 2024, 117 (02)
  • [2] Immune Checkpoint Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 is Upregulated and Independently Predicts Unfavorable Prognosis in Bladder Urothelial Carcinoma
    Lin, Guobing
    Ye, Haibo
    Wang, Junwei
    Chen, Song
    Chen, Xuanyu
    Zhang, Cunming
    NEPHRON, 2019, 141 (04) : 256 - 264
  • [3] Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 Possesses Prognostic Significance and Promotes Progression of Papillary Thyroid Cancer
    Niu, Yongzhi
    Huang, Yichuan
    Dong, Anbing
    Sun, Yinghe
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 1509 - 1516
  • [4] Clinical Value of Human Endogenous Retrovirus-H Long Terminal Repeat Associating 2 (HHLA2) in Small Cell Lung Cancer
    Zhang, Xiuqin
    Qin, Yan
    Chen, Xu
    Xiong, Mengrui
    Shu, Song
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2024, 23
  • [5] The Expression Patterns and Associated Clinical Parameters of Human Endogenous Retrovirus-H Long Terminal Repeat-Associating Protein 2 and Transmembrane and Immunoglobulin Domain Containing 2 in Oral Squamous Cell Carcinoma
    Xiao, Yao
    Li, Hao
    Yang, Lei-Lei
    Mao, Liang
    Wu, Cong-Cong
    Zhang, Wen-Feng
    Sun, Zhi-Jun
    DISEASE MARKERS, 2019, 2019
  • [6] THE LONG TERMINAL REPEAT SEQUENCES OF A NOVEL HUMAN ENDOGENOUS RETROVIRUS
    OCONNELL, CD
    COHEN, M
    SCIENCE, 1984, 226 (4679) : 1204 - 1206
  • [7] Enhancer Activity of Solitary Long Terminal Repeat of Human Endogenous Retrovirus K
    A. N. Domansky
    S. B. Akopov
    Yu. B. Lebedev
    L. G. Nikolaev
    E. D. Sverdlov
    Russian Journal of Bioorganic Chemistry, 2002, 28 : 308 - 311
  • [8] Enhancer activity of solitary long terminal repeat of human endogenous retrovirus K
    Domansky, AN
    Akopov, SB
    Lebedev, YB
    Nikolaev, LG
    Sverdlov, ED
    RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY, 2002, 28 (04) : 308 - 311
  • [9] H Long Terminal Repeat-Associating 2 (HHLA2) is a Biomarker of Advanced Stage Hepatocellular Carcinoma and Promotes Tumor Cell Development In Vitro
    Luo, Min
    Xiong, Yao
    Lin, Yan
    Liang, Rong
    Li, Yongqiang
    Ge, Lianying
    MEDICAL SCIENCE MONITOR, 2021, 27
  • [10] Analysis of transcriptional regulatory sequences in the human endogenous retrovirus W long terminal repeat
    Lee, WJ
    Kwun, HJ
    Jang, KL
    JOURNAL OF GENERAL VIROLOGY, 2003, 84 : 2229 - 2235
1234